Doubting safety of Covaxin, a native vaccine against Covid19, and double standards for phyto-medicine in the use of biotechnology

 

On this historic day, the 3rd January 2021, the Drug Controller General of India has given an emergency approval to two vaccines, Covishield of Oxford-AstraZeneca and Covaxin of Bharat Biotech-NIV-ICMR to fight the Covid19 coronavirus that has caused pandemic (https://pib.gov.in/PressReleasePage.aspx?PRID=1685761). With approval, there is a sense of relief amongst people as this virus Co-V2 has so far infected more than 10 million and caused deaths of about 1,46,000 so far in India and a lot more world-wide within a short time of one year. Covishield is also approved in UK after satisfactory results of 3rd phase of trials involving more than 26,000 volunteers in many countries of the Europe and also in India.

Covaxin, an indigenous vaccine is developed using inactivated virus which still retains its ability to develop antibodies inside the body to fight the live viral infection, as and when that occurs. This approach to develop vaccine is time-tested as it has been done for many others like for hepatitis, polio etc. in the past. Covaxin entered into the 3rd phase of trial in mid-November 2020 with 23000 volunteers, less than targetted 26000; and this number of volunteers remained lower than that for Covishield, as at some places, there were not enough.

This has given a stick for the opposition to create the doubts about the safety of Covaxin. The Samajwadi Party (SP) leader, Akhilesh Yadav called it a BJP vaccine and like BJP telling lies, he felt that this vaccine cannot be trusted. So was the case with Shri Shashi Tharoor, Member of Parliament belonging to Indian National Congress, who questioned unnecessary haste in granting an approval in view of limited number of volunteers for incomplete duration, and with limited results. One SP leader also feared that this vaccine might be an attempt to reduce population by the party in governance. Thus, politics soon cast a shadow over the good news of vaccine approval.

Apart from trials on animals, vaccines being medicine directly applied topically or injected into humans are to be tested on a large scale. Safety and efficacy is the must. In case of vaccine, immunogenicity in terms of durational efficacy is an additional consideration. Mr Harsh Vardhan, Health Minister repeatedly said that there is no compromise on these criteria. And as Covishield is produced in about 5 million doses by our Serum Institute of India (SII), Pune; this will be first administered to those in priority such as health workers.  India is in unique position, as it has been a largest producer of vaccines in the world. With license from Oxford-AstraZeneca, Covishield already produced by SII in expectation of emergency approval is reasonably priced. And some states will provide it to the people free of cost. Soon to follow will be Covaxin of Bharat Biotech which is being produced in large numbers and made available at reasonable price.

Normally, vaccine development takes many years, but considering the nature of disease on a pandemic scale, vaccines are developed within a short period as the knowledge of developing medicines has improved along with technologies associated (see below photo from Pandey et al. 2020 Life Sci. https://dx.doi.org/10.1016%2Fj.lfs.2020.117956).

Fig credit: Pandey et al. 2020 as above

 


 

Controversy over vaccine is also due to fears of the side effects rather than the benefits of main effects of vaccine. Allergic reactions are common and differ from person to person and over time in the same person. Most of these reactions are temporary lasting for hours at the most. Even in daily lives, we come across allergic reaction, sometime to the food or its contents despite the fact we might be eating it for many days, or months or even years. Recently, I observed eating of pickles is causing rashes, that was not the case in the past. Exposing skin to the sunshine in this winter showed a part of skin showing redness followed by itching. These allergic reactions last for few hours. It is heard that only some allergies prove fatal to few people.

This controversy with political twist reminds me of safety tests required for development of pesticides, often called phyto-medicines that protect crops against damage of pests. Safety tests or toxicological tests are carried out as per protocol before approval of these phyto-medicine by the regulatory authorities. Efficacy and safety are the main considerations hereto for approval just like for vaccine or therapeuticals. Most environmental concerns are addressed along especially for phyto-medicine, if not so rigorously for human-medicines. Yet, some often criticise as they feel that these tests are not tried on a long term basis or over generations in the test animals, despite the fact that these tests are developed in harmony based upon the knowledge and past experience. I see some parallel here but tweaking for human medicine.

Are there double standards being used in the development of medicines by the regulatory authorities? …… in the name of pandemic nature of disease or need for exigency to find cure? I do not mean, it should be business as usual for human medicine, neither I bother about few hundred less or more when testing is done in thousands. At the same time, certainly, for phyto-medicines too, it should be time-bound processing for approval, as food security is of equally great concern. Only on ensuring food security, we will be ensuring human sustenance. Further, biotechnology use in human medicine development, and in this case for Covishield vaccine, is acceptable to the regulatory authorities even in Europe. This technology has brought in a revolution in terms of efficacy, efficiency and accuracy, for development of products of importance to humans. However, in case of phyto-medicines, biotechnology or genetic engineering is not acceptable to the regulatory authorities de facto, if not de jure, no matter how important these and other scientifically proven technologies are for crop improvement and protection.

It is time to look forward to the use of technology for humankind.

 

Comments

Post a Comment

Popular posts from this blog

How robust is our pesticide policy? A case of waiting period or post-harvest interval for safe consumption of produce

Image
Top: Saurashtra farmer who was keen to offer us a gift of maize, but for spray a day before; Bottom: Ready to spray with mixture on cotton.   As early as 1985, India recognised importance of integrated pest management to achieving optimal crop protection in its agricultural policy. This policy also envisaged reduction in the use of synthetic pesticides and increase in eco-friendly safe tactics in the agroecosystem. Safety to all is pivotal of crop protection policy. However, synthetic pesticides remained the bulwark of integrated pest management in agriculture. In fact, consumption of synthetic pesticides has increased over the past two decades from about 45,000 tons to about 60,000 tons. And hence, it has become necessary that we use pesticides judiciously so that farmers save their farm produce from the ravages of pests and at the same time, consumers get foodgrains and other farm produce that are safe to eat. Some years back, I was reading the data on major uses of pesticides, e
Read more

Probit Analysis of bioassays: Sure, you are seriously talking about it

Image
    After reviewing a manuscript, I thought of talking to my friend who works in the prestigious Government institution to know as to how he estimates various parameters of toxicity like LC50, fiducial limits [FL] or Confidence intervals [CI], intercept. And this reminded me of my days as a M.Sc. student when I would do these calculations using a Facit® manual calculator on a tabulated sheet that our insect toxicology teacher, Dr. B.S. Atri would provide us. It was tedious work involving filling of columns like concentrations, log concentrations, % mortality, their transformation into probits, weighting coefficients, empirical probits, expected probits, working probits and other parameters meticulously up to three decimal points until we came to an equation, y=a+bx, where y is 5.0, a, an intercept and b, a slope and x (log LC50) is what we will calculate. For 95% FL, we used two equations, m1=m-1.96 √ V and m2=m+.6 √ V where m1, m2, lower and upper FLs of LC50, √ square root of varian
Read more

Pheromone-based Crop Protection: Mating Disruption technology needs many researchable inputs to succeed sustainably

Image
Moths of the pink bollworm in the pheromone trap Farmers' gathering: pheromone MD formulation, PB knot tied on stem of cotton larva of the pink bollworm feeding inside the raw cotton boll It was in mid-1980s and early 1990s that the American bollworm caused havoc to cotton production in the country leading some farmers to commit suicides in the erstwhile state of Andhra Pradesh, Maharashtra and others, as they had taken loans in expectation of bumper yields. Farmers did not believe that this bollworm can be a key pest, reducing their cotton production significantly. The pest insect had developed resistance to most of insecticides used in cotton and thrived well. Insecticide-based control of pests was a big failure, affecting environment and health of all stakeholders. Everyone scrambled for solution. Botanicals like neem, microbials like nucleopolyhedrosis virus, and parasites like Trichogramma chilonis were reported to be alternate to insecticides. The need-based use of insect
Read more